Allergan Rejects Valeant's Latest Offer

Allergan Rejects Valeant's Latest Offer

Patrick T. Fallon/Bloomberg

Allergan, the maker of Botox, said in a statement that it turned down the offer of $72 a share in cash and 0.83 a share of Valeant stock.